Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.

Kazuhiko IkedaHitoshi OhtoMinami Yamada-FujiwaraYoshiki OkuyamaShin-Ichiro FujiwaraKazuo MuroiTakehiko MoriKinuyo KasamaHeiwa KanamoriTohru IsekiTokiko Nagamura-InoueKazuaki KamedaJunya KandaKazuhiro NagaiNobuharu FujiiTakashi AshidaAsao HiroseTsutomu TakahashiKeiji MinakawaRyuji Tanosaki

Published in: Transfusion (2020)

We should be aware of product volume and specific HCI-AEs such as nausea and vomiting in small patients including children.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
young adults
single cell
low dose
prognostic factors
bone marrow
peritoneal dialysis
cell therapy
stem cells
patient reported outcomes